Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-02-06 | Ms. Breanne D. AntichExec. VP & CTO | -800,00 | 9,79k | Derivative Exercise and Sale | 27,40 - 40,05 | 8,36k | - |
| 2026-02-05 | Ms. Marci A. BasichExec. VP, Treasurer & CFO | -477,00 | 5,38k | Derivative Exercise and Sale | 28,23 - 39,50 | 17,18k | - |
| 2026-02-05 | Mr. Jonathan Arthur FischerCOO, President & Secretary | -2,00k | 47,66k | Derivative Exercise and Sale | 15,67 - 39,50 | 19,61k | - |
| 2026-02-02 | Ms. Marci A. BasichExec. VP, Treasurer & CFO | -4,72k | 44,68k | Derivative Exercise and Sale | 28,23 - 39,52 | 17,18k | - |
| 2026-02-02 | Mr. Matthew J. DeBordExec. VP & Chief Lending Officer | -3,81k | 55,41k | Derivative Exercise and Sale | 16,87 - 39,53 | 7,77k | - |
| 2026-01-30 | Ms. Andrea M. ClintonIndependent Director | -1,60k | 20,31k | Derivative Exercise and Sale | 16,87 - 39,19 | 8,91k | - |
| 2025-12-15 | Mr. Matthew J. DeBordExec. VP & Chief Lending Officer | -5,20k | 43,32k | Derivative Exercise and Sale | 16,87 - 37,51 | 7,77k | - |
| 2025-12-11 | Mr. Michael John StoneyIndependent Chairperson | -1 000,00 | 21,32k | Derivative Exercise and Sale | 15,67 - 36,99 | 9,04k | - |
| 2025-09-26 | Ms. Breanne D. AntichExec. VP & CTO | -64,00 | 2,19k | Sale to Issuer | 34,20 | 8,36k | -0,76% |
| 2025-09-26 | Mr. Robert A. DruggeDirector | -50,00 | 1,71k | Sale to Issuer | 34,20 | 45,62k | -0,11% |
| 2025-09-26 | Ms. Kathy D. LeodlerIndependent Director | -200,00 | 6,84k | Sale to Issuer | 34,20 | 1,74k | -10,34% |
| 2025-09-26 | Mr. Michael John StoneyIndependent Chairperson | -74,00 | 2,53k | Sale to Issuer | 34,20 | 9,04k | -0,81% |
| 2025-09-24 | Mr. Michael John StoneyIndependent Chairperson | -81,00 | 2,79k | Sale to Issuer | 34,40 | 9,11k | -0,88% |
| 2025-09-24 | Ms. Kathy D. LeodlerIndependent Director | -215,00 | 7,40k | Sale to Issuer | 34,40 | 1,94k | -10,00% |
| 2025-09-24 | Mr. Robert A. DruggeDirector | -50,00 | 0,00 | Sale to Issuer | - | 45,67k | -0,11% |
| 2025-09-24 | Ms. Breanne D. AntichExec. VP & CTO | -95,00 | 3,27k | Sale to Issuer | 34,40 | 8,43k | -1,11% |
| 2025-08-18 | Ms. Breanne D. AntichExec. VP & CTO | -7,00k | 23,80k | Derivative Exercise and Sale | 27,14 - 32,55 | 6,52k | - |
| 2025-08-13 | Mr. Robert A. DruggeDirector | 2,00k | 21,42k | Derivative Exercise and Retained Stock | 10,71 | 45,02k | 4,65% |
| 2025-08-13 | Mr. David A. SmithIndependent Director | -164,00 | 3,74k | Derivative Exercise and Sale | 10,71 - 33,50 | 17,77k | - |
| 2025-07-29 | Mr. David A. SmithIndependent Director | -836,00 | 19,05k | Derivative Exercise and Sale | 10,71 - 33,50 | 17,77k | - |
| 2025-07-29 | Mr. Todd W. Van CiseInitié | -7,00k | 228,55k | Vente | 32,65 | 4,61k | -60,30% |
| 2025-07-25 | Ms. Marci A. BasichExec. VP, Treasurer & CFO | -300,00 | 9,98k | Vente | 33,25 | 15,18k | -1,94% |
| 2025-07-25 | Ms. Andrea M. ClintonIndependent Director | -3,80k | 23,20k | Derivative Exercise and Sale | 16,87 - 32,98 | 8,21k | - |
| 2025-06-17 | Mr. Dean J. BrydonCEO & Director | 811,00 | 8,69k | Derivative Exercise and Retained Stock | 10,71 | 63,06k | 1,30% |
| 2025-06-17 | Mr. Dean J. BrydonCEO & Director | -1,19k | 23,00k | Derivative Exercise and Sale | 10,71 - 30,05 | 63,06k | - |
| 2025-06-16 | Ms. Breanne D. AntichExec. VP & CTO | -152,00 | 4,61k | Vente | 30,31 | 6,52k | -2,28% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.